Preview

Medical Visualization

Advanced search

Synthesis, quantum chemistry analysis and pre-clinical in vivo evalution of magnetic resonance imaging abilities of paramagnetic manganese complex with 2,3-dimercaptosuccinate (succimang)

https://doi.org/10.24835/1607-0763-2019-3-133-143

Abstract

Aim of the study. We have carried out the synthesis of complex of Manganese(II) with dimercaptosuccinic acid (DMSA), applied the quantum chemistry analysis for evaluation of most stable form of the Mn- DMSA complex and studied it’s uptake and imaging properties in normal and tumoral tissues in veterinary patients (cats with tumors)
Material and methods. The synthesis of the 2.3-dimercaptosuccinic acid (COOH-CHSH-CHSH-COOH) has been carried out using modified technique proposed by A.I. Busev [Busev A.I. 1972]. Using phantoms filled in with 0.05 mM – 16 mM solutions of the agent we quantified the R1 relaxivity. Imaging properties of the 0.5 M solution of the Mn-(DMSA)2 were evaluated when performing the  contrastenhanced studies in veterinary patients (cats with adenofibrous tumors and angiofibromas, nine animals) using T1-w spin-echo mode.
Results. As result of quantum chemistry analysis it was shown that the most stable complex of Mn(II) with DMSA is the molecule Mn-(DMSA)2. The R1 relaxivity of the Mn-(DMSA)2 complex in the water solution was as high as 3.2 1/(mM*s). In normal control animals the Mn-(DMSA)2 provided highly intensive enhancement of renal parenchyma and mild enhancement of liver, spleen and bone marrow. In animals with tumors the Mn-(DMSA)2 enhanced the T1-w spin-echo images of angiofibromas and fibroadenomas in both peripheral (index of enhancement = 1.87 ± 0.09, p < 0.01) and central (index of enhancement = 1.59 ± 0.07, p < 0.01) parts of the tumor.
Conclusion. The imaging properties of the Mn-(DMSA)2 make an argue for real possibility of production of new non-Gadolinium paramagnetic contrast agents specific to tumors. Further study of the Mn-(DMSA)2 complex as paramagnetic contrast agent is of interest and useul.

About the Authors

W. Yu. Ussov
National Research Tomsk Polytechnic University, Research Institute of Cardiology of the Tomsk National Research Medical Center of the Russian Academy of Sciences
Russian Federation

Doct. of med. sci., Professor, Head of X-ray and Tomographic Methods of Diagnosis

Kievskaya 111, 634012 Tomsk, Russia

Phone: +7-903-951-26-



V. D. Filimonov
National Research Tomsk Polytechnic University
Russian Federation

Doct. of chem. sci., Professor of the Department of Organic Chemistry and Biologically Active Substances

Tomsk



M. L. Belyanin
National Research Tomsk Polytechnic University
Russian Federation

Cand. of chem. sci., Assistant Professor of Organic Chemistry and Biologically Active Substances Department

Tomsk



A. I. Bezlepkin
Vetrinary research clinic “Aibolit” Ltd
Russian Federation

Director

Tomsk



M. A. Lucic
Center of Imaging Diagnostic, Sremska Kamenica
Czechoslovakia
Doctor of Medicine, Professor


A. Yu. Kovalenko
Research Institute of Cardiology of the Tomsk National Research Medical Center of the Russian Academy of Sciences
Russian Federation

Postgraduate medical student of X-ray and Tomographic Methods of Diagnosis

Tomsk



Yu. V. Rogovskaya
Research Institute of Cardiology of the Tomsk National Research Medical Center of the Russian Academy of Sciences
Russian Federation

Cand. of med. sci., Head of the Department of Pathomorphology

Tomsk



N. L. Shimanovskiy
Российский Национальный исследовательский медицинский университет имени Н.И. Пирогова
Russian Federation

Corresponding Member of RAS, Doctor of Medicine, Professor, Head of the Department of acadecician P.V. Segeev Molecular Pharmacology, and Radiobilogy

Moscow



References

1. Ussov W.Yu., Belyanin M.L., Kodina G.E., Afanasyev S.A., Bezlepkin A.I., Gulyaev V.M., Shimanovsky N.L. Myocardial MRI Using Paramagnetic Contrast Enhancement With Manganese-Metoxyisobutylisonitryle (Mn-MIBI) in Animals. Medical Visualization. 2016; 1: 31–38. (In Russian)

2. Shimanovsky N.L. 20 years of clinical application of magnetic resonance contrast agents. Diagnostic and intervention radiology. 2009; 3 (1): 5–15. (In Russian)

3. Ussov W.Yu., Belyanin M.L., Kovalenko A.Yu., Bezlepkin A.I., Filimonov V.D., Shimanovsky N.L. Evaluation of manganese dimercaptosuccinate (Mn-DMSA) complex as contrast agent for paramagnetic enhancement in MRI studies of malignant fibroepithelial tumors in animals. Russian Electronic Journal of Radiology (REJR). 2017; 7 (4): 108–116

4. Blower P.J., Lam A.S., O'Doherty M.J., Kettle A.G., Coakley A.J., Knapp F.F. Jr. Pentavalent rhenium-188 dimercaptosuccinic acid for targeted radiotherapy: synthesis and preliminary animal and human studies. Eur. J. Nucl. Med. 1998; 25 (6): 613–621.

5. On 70-th Anniversary of the Professor I.Ya. Postovsky. Chemistry of heterocyclic compounds. 1968; (1): 186–188. (In Russian)

6. Ussov W.Yu., Belyanin M.L., Kodina G.E., Afanasyev S.A., Bezlepkin A.I., Gulyaev V.M., Shimanovsky N.L. Myocardial MRI Using Paramagnetic Contrast Enhancement With Manganese-Metoxyisobutylisonitryle (Mn-MIBI) in Animals. Medical Visualization. 2016; 1: 31–38. (In Russian)

7. van Eijkeren J.C., Olie J.D., Bradberry S.M., Vale J.A., de Vries I., Clewell H.J. 3rd, Meulenbelt J., Hunault C.C. Modeling the effect of succimer (DMSA; dimercaptosuccinic acid) chelation therapy in patients poisoned by lead. Clin. Toxicol. (Philad.). 2017; 55 (2): 133–141. http://doi.org/10.1080/15563650.2016.1263855.

8. Ussov W.Yu., Belyanin M.L., Kovalenko A.Yu., Bezlepkin A.I., Filimonov V.D., Shimanovsky N.L. Evaluation of manganese dimercaptosuccinate (Mn-DMSA) complex as contrast agent for paramagnetic enhancement in MRI studies of malignant fibroepithelial tumors in animals. Russian Electronic Journal of Radiology (REJR). 2017; 7 (4): 108–116

9. Busev A.I. Synthesis of new organic reagents for nonorganic analysis. M.: MSU Publ., 1972: 116–118. (In Russian)

10. On 70-th Anniversary of the Professor I.Ya. Postovsky. Chemistry of heterocyclic compounds. 1968; (1): 186–188. (In Russian)

11. Zevatskiy Yu.E., Samoilov D.V. Empiric method of quantification of influence of dissolver on dissociation constants of carbonic acids. Zhurnal organicheskoi chimii. 2008; 44 (1): 59–68. (In Russian)

12. van Eijkeren J.C., Olie J.D., Bradberry S.M., Vale J.A., de Vries I., Clewell H.J. 3rd, Meulenbelt J., Hunault C.C. Modeling the effect of succimer (DMSA; dimercaptosuccinic acid) chelation therapy in patients poisoned by lead. Clin. Toxicol. (Philad.). 2017; 55 (2): 133–141. http://doi.org/10.1080/15563650.2016.1263855.

13. Kaviani S., Shahab S., Sheikhi M., Ahmadianarog M. DFT study on the selective complexation of meso-2,3-dimercaptosuccinic acid with toxic metal ions (Cd2+, Hg2+ and Pb2+) for pharmaceutical and biological applications. J. Molec. Struct. 2019; 1176: 901–907.

14. Busev A.I. Synthesis of new organic reagents for nonorganic analysis. M.: MSU Publ., 1972: 116–118. (In Russian)

15. Pettersson H., Slone R.M., Spanier S., Gillespie Th., Fitzsimmons J.R., Scott K.N. Musculoskeletal Tumors: T1 and T2 relaxation Times. Radiology. 1988; 167: 783–785.

16. Zevatskiy Yu.E., Samoilov D.V. Empiric method of quantification of influence of dissolver on dissociation constants of carbonic acids. Zhurnal organicheskoi chimii. 2008; 44 (1): 59–68. (In Russian)

17. Hernandez-Valdes D., Blanco-Gonsalez A., Rodriguez-Riera Z., Haza J., Ducat-Pages L., Pizarro-Lou L. Theoretical study of Re and Tc-DMSA complexes. Nucl. Med. Biol. 2014. http://doi.org/10.1016/j.nucmedbio.2014.05.011.

18. Kaviani S., Shahab S., Sheikhi M., Ahmadianarog M. DFT study on the selective complexation of meso-2,3-dimercaptosuccinic acid with toxic metal ions (Cd2+, Hg2+ and Pb2+) for pharmaceutical and biological applications. J. Molec. Struct. 2019; 1176: 901–907.

19. The Chemistry of Contrast Agents in Medical Resonance Imaging. 2nd ed; eds by L. Helm, A.E. Mehrbach, E Troth. J. Wiley, 2013. 496 p.

20. Pettersson H., Slone R.M., Spanier S., Gillespie Th., Fitzsimmons J.R., Scott K.N. Musculoskeletal Tumors: T1 and T2 relaxation Times. Radiology. 1988; 167: 783–785.

21. Belyanin M.L., Prvulovich M., Karpova G.V., Bezlepkin A.I., Fedorenko E.V., Churin A.A., Filimonov V.D., Ussov W.Yu. Synthesis and evaluation of mangapentetate as paramagnetic contrast agent for MRI. Diagnostic and Interventional radiology. (Moscow). 2008; 2 (1): 75–86. (In Russian)

22. Hernandez-Valdes D., Blanco-Gonsalez A., Rodriguez-Riera Z., Haza J., Ducat-Pages L., Pizarro-Lou L. Theoretical study of Re and Tc-DMSA complexes. Nucl. Med. Biol. 2014. http://doi.org/10.1016/j.nucmedbio.2014.05.011.

23. Zhen Ye, Eun-Kee Jeong, Xueming Wu, Mingqian Tan, Shouyu Yin, Zheng-Rong Lu. Polydisulfide Manganese(II) Complexes as Non-Gadolinium Biodegradable Macromolecular MRI Contrast Agents. J. Magn. Reson. Imaging. 2012; 35 (3): 737–744. http://doi.org/10.1002/jmri.22848.

24. The Chemistry of Contrast Agents in Medical Resonance Imaging. 2nd ed; eds by L. Helm, A.E. Mehrbach, E Troth. J. Wiley, 2013. 496 p.

25. Burilova E.A., Ziyatdinova A.B., Zyavkina Yu.I., Amirov R.R. Influence of water-soluble polymers on the formation of Manganese(II) complexonates in solution. II/ Complexes with DTPA. Scientific Proceedings of Kazan University. Natural Sciences. 2013; 155 (2): 26–38. (In Russian)

26. Belyanin M.L., Prvulovich M., Karpova G.V., Bezlepkin A.I., Fedorenko E.V., Churin A.A., Filimonov V.D., Ussov W.Yu. Synthesis and evaluation of mangapentetate as paramagnetic contrast agent for MRI. Diagnostic and Interventional radiology. (Moscow). 2008; 2 (1): 75–86. (In Russian)

27. Montoriol P.F., Mons A., Da Ines D., Bourdel N., Tixier L., Garcier J.M. Fibrous tumours of the ovary: aetiologies and MRI features. Clin. Radiol. 2013; 68 (12): 1276–1283. http://doi.org/10.1016/j.crad.2013.07.005.

28. Zhen Ye, Eun-Kee Jeong, Xueming Wu, Mingqian Tan, Shouyu Yin, Zheng-Rong Lu. Polydisulfide Manganese(II) Complexes as Non-Gadolinium Biodegradable Macromolecular MRI Contrast Agents. J. Magn. Reson. Imaging. 2012; 35 (3): 737–744. http://doi.org/10.1002/jmri.22848.

29. Djokić D., Janković D., Nikolić N. Preparation and in vivo evaluation of 90Y-meso-dimercaptosuccinic acid (90Y-DMSA) for possible therapeutic use: comparison with 99mTc-DMSA. Cancer Biother. Radiopharm. 2009; 24 (1): 129–136. http://doi.org/10.1089/cbr.2008.0499.

30. Burilova E.A., Ziyatdinova A.B., Zyavkina Yu.I., Amirov R.R. Influence of water-soluble polymers on the formation of Manganese(II) complexonates in solution. II/ Complexes with DTPA. Scientific Proceedings of Kazan University. Natural Sciences. 2013; 155 (2): 26–38. (In Russian)

31. Hirano T., Otake H., Kazama K., Wakabayashi K., Zama A., Shibasaki T., Tamura M., Endo K. Technetium-99m(V)- DMSA and thallium-201 in brain tumor imaging: correlation with histology and malignant grade. J. Nucl. Med. 1997; 38 (11): 1741–1749.

32. Montoriol P.F., Mons A., Da Ines D., Bourdel N., Tixier L., Garcier J.M. Fibrous tumours of the ovary: aetiologies and MRI features. Clin. Radiol. 2013; 68 (12): 1276–1283. http://doi.org/10.1016/j.crad.2013.07.005.

33. Skalny A.V. Bioelementology as an interdisciplinary integrative approach in life sciences: Terminology, classification, perspectives. J. Trace Elements Med. Biol. 2011; 25: 3–10.

34. Djokić D., Janković D., Nikolić N. Preparation and in vivo evaluation of 90Y-meso-dimercaptosuccinic acid (90Y-DMSA) for possible therapeutic use: comparison with 99mTc-DMSA. Cancer Biother. Radiopharm. 2009; 24 (1): 129–136. http://doi.org/10.1089/cbr.2008.0499.

35. Hirano T., Otake H., Kazama K., Wakabayashi K., Zama A., Shibasaki T., Tamura M., Endo K. Technetium-99m(V)- DMSA and thallium-201 in brain tumor imaging: correlation with histology and malignant grade. J. Nucl. Med. 1997; 38 (11): 1741–1749.

36. Skalny A.V. Bioelementology as an interdisciplinary integrative approach in life sciences: Terminology, classification, perspectives. J. Trace Elements Med. Biol. 2011; 25: 3–10.


Review

For citations:


Ussov W.Yu., Filimonov V.D., Belyanin M.L., Bezlepkin A.I., Lucic M.A., Kovalenko A.Yu., Rogovskaya Yu.V., Shimanovskiy N.L. Synthesis, quantum chemistry analysis and pre-clinical in vivo evalution of magnetic resonance imaging abilities of paramagnetic manganese complex with 2,3-dimercaptosuccinate (succimang). Medical Visualization. 2019;(3):133-143. (In Russ.) https://doi.org/10.24835/1607-0763-2019-3-133-143

Views: 977


ISSN 1607-0763 (Print)
ISSN 2408-9516 (Online)